Brazil vs Democratic Republic of Congo: Antiretroviral therapy coverage (% of people living with HIV)
Brazil
73.0%
in 2024
Democratic Republic of Congo
71.0%
in 2024
Brazil rank
71st
Democratic Republic of Congo rank
74th
Antiretroviral therapy coverage (% of people living with HIV) over time
- Brazil
- Democratic Republic of Congo
How they compare
Brazil currently reports 73.0% against 71.0% in Democratic Republic of Congo, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Brazil ahead.
Brazil ranks 71st and Democratic Republic of Congo ranks 74th of 143 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.8% | 1.8% | 41.0% | Brazil |
| 2010s | 59.9% | 22.0% | 37.9% | Brazil |
| 2020s | 70.0% | 65.2% | 4.8% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Brazil or Democratic Republic of Congo?
- Brazil, at 73.0% against 71.0% in Democratic Republic of Congo as of 2024.
- What is the difference in antiretroviral therapy coverage between Brazil and Democratic Republic of Congo?
- 2.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Democratic Republic of Congo?
- 25 years are reported by both, from 2000 to 2024.
- How do Brazil and Democratic Republic of Congo rank globally for antiretroviral therapy coverage?
- Brazil ranks 71st and Democratic Republic of Congo ranks 74th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.